We expect another solid top line from Swedish Match in Q3, with still-strong momentum in the US smoke-free business. However, we also see margin pressure from the ongoing channel shift in the Nordics and higher marketing spend in the US. That said, we expect the revised PMI bid to overshadow the Q3 report. We reiterate our HOLD, but have raised our target price to SEK116 (106) to reflect PMI’s increased bid.
With the offer period for PMI’s bid still open, the Q2 results were less relevant – although the c5% top-line beat illustrated still-strong Zyn momentum, which arguably could fuel deal resisters. However, we still find it difficult to assess how the big shareholders will ultimately respond once the offer period ends. We therefore reiterate our HOLD and SEK106 target price, which is in line with PMI’s current offer.
Shortly before yesterday’s Q1 results, Phillip Morris announced a SEK106/share offer for Swedish Match. This news in our view overshadowed a quarter that, apart from confirming the Zyn growth story, was rather uneventful. We recognise the logic behind the approach by Phillip Morris and see no obvious alternative suitor that could drive the price higher, unless there is a potential LBO. We have raised our target price to SEK106 (87) in line with the offer by Phillip Morris, but downgraded to HOLD...
Largely in line with consensus, we expect strong Q1 revenue growth of c12.1% (consensus 11.9%), but with margins under pressure. We expect strong Zyn volume growth of c38%, driven by increased promotional activity in the US, which we expect to add to the margin pressure. However, we view the margin pressure as a temporary and welcome trade-off that should enable Swedish Match to secure a larger share of a highly attractive market. We reiterate our BUY and SEK87 target price.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.